FDA Approved: INDOMETHACIN — Supplemental Application (XLCare Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Indomethacin submitted by XLCare Pharmaceuticals Inc. under ANDA 091240.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dysmenorrhea
• Gout
• Osteoarthritis
• Patent Ductus Arteriosus
• Rheumatoid Arthritis

Drugs mentioned

• INDOMETHACIN (INDOMETHACIN)

Snippet

SUPPL AP for INDOMETHACIN (INDOMETHACIN)